On Wednesday I looked through countless broker notes to find three buy ratings that I felt stood out.
Today I thought I would do the same for sell ratings. Here are three shares tipped as sells by broker this week:
A2 Milk Company Ltd (ASX: A2M)
Analysts at Citi have retained their sell rating but lifted the price target on the infant formula and dairy company’s shares to $9.65 despite its strong full-year results. According to the note, the broker has concerns over excess inventory in the daigou channels and believes this will become apparent when the company reports its first-half results next year. Citi expects this inventory build-up to lead to slowing sales. If Citi is correct with the inventory build-up then I believe investors should be concerned. However, I’m giving the company the benefit of the doubt for now until the potential build-up is visible.
Altium Limited (ASX: ALU)
According to a note out of Ord Minnett, it has retained its sell rating but increased the price target on this tech star’s shares to $17.70 following the release of its results late on Tuesday. Although Altium’s results came in ahead of the broker’s expectations and management has confirmed that it expects to hit its 2020 targets, the broker isn’t a fan of its valuation. Ord Minnett expects Altium to deliver earnings per share of 37.3 cents in FY 2019, meaning its shares are priced at 78x forward earnings. This isn’t a good enough risk/reward for the broker. I think that its analysts make a valid point and taking a little bit of profit off the table might be prudent after such an incredible gain this week. But I would be very surprised if its shares fell as low as the broker’s price target.
Asaleo Care Ltd (ASX: AHY)
A note out of Citi reveals that its analysts have retained their sell rating and reduced the price target on the personal care products company’s shares to 65 cents. The broker didn’t appear to be overly impressed with Asaleo Care’s first half results and fears higher pulp prices could weigh on its performance. The market doesn’t seem to agree with this view, though, Asaleo Care’s shares are up significantly since the release of its results. I’d class it as a hold for now.
Finally, here are three buy rated growth shares that I think investors ought to consider today.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk and Altium. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.